Systems Biology in Cancer Research and Drug Discovery

Systems Biology in Cancer Research and Drug Discovery provides a unique collection of chapters, by world-class researchers, describing the use of integrated systems biology and network modeling in the cancer field where traditional tools have failed to deliver expected promise. This book touches fou...

Full description

Bibliographic Details
Other Authors: Azmi, Asfar S. (Editor)
Format: eBook
Language:English
Published: Dordrecht Springer Netherlands 2012, 2012
Edition:1st ed. 2012
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02101nmm a2200313 u 4500
001 EB000401671
003 EBX01000000000000000254724
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9789400748194 
100 1 |a Azmi, Asfar S.  |e [editor] 
245 0 0 |a Systems Biology in Cancer Research and Drug Discovery  |h Elektronische Ressource  |c edited by Asfar S Azmi 
250 |a 1st ed. 2012 
260 |a Dordrecht  |b Springer Netherlands  |c 2012, 2012 
300 |a XII, 424 p  |b online resource 
653 |a Bioinformatics 
653 |a Computational and Systems Biology 
653 |a Medicine / Research 
653 |a Biology / Research 
653 |a Cancer 
653 |a Biomedical Research 
653 |a Cancer Biology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
028 5 0 |a 10.1007/978-94-007-4819-4 
856 4 0 |u https://doi.org/10.1007/978-94-007-4819-4?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 610.72 
520 |a Systems Biology in Cancer Research and Drug Discovery provides a unique collection of chapters, by world-class researchers, describing the use of integrated systems biology and network modeling in the cancer field where traditional tools have failed to deliver expected promise. This book touches four applications/aspects of systems biology (i) in understanding aberrant signaling in cancer (ii) in identifying biomarkers and prognostic markers especially focused on angiogenesis pathways (iii) in unwinding microRNAs complexity and (iv) in anticancer drug discovery and in clinical trial design. This book reviews the state-of-the-art knowledge and touches upon cutting edge newer and improved applications especially in the area of network modeling. It is aimed at an audience ranging from students, academics, basic researcher and clinicians in cancer research. This book is expected to benefit the field of translational cancer medicine by bridging the gap between basic researchers, computational biologists and clinicians who have one ultimate goal and that is to defeat cancer